Empesertib | Empesertib : Inhibitor of TTK
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
TTK
  • IC50:1.7 nM
  • IC50:53 nM
  • IC50:260 nM
Inhibitor
100 nM

Selectivity

In Vitro Selectivity Assessment

Potency: % inh. - JNK2 54% @ 1 uM, JNK3 84% @ 1 uM

Selectivity Assessment Description:
Empesertib only inhibits two kinases, JNK2 and JNK3, more than 50% at a concentration of 1 μmol/L ...

Potency
Cellular
In Vitro

TTK

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.9b02035

In Vivo Validations

Mouse, Rat, Dog
Dose: 0.5, 1, 2 mg/Kg
Route of delivery: Intravenous, Oral
Plasma half life: 4.9 (M), 14 59 (M), (R), 6.3 (D) h IV
Systemic clearance: 0.69 (M), 0.19 (R), 1.4 (D) L/h/Kg IV

DOI Reference: 10.1021/acs.jmedchem.9b02035

Orthogonal Probes def

CFI-402257
BAY-1217389

Chemical Information

Molecular Formula C29H26FN5O4S
SMILEs COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1
InChI InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1
Molecular weight 559.17 Da
AlogP 5.4333
HBond acceptors 9
HBond donors 2
Atoms 66

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for Empesertib

Probe Empesertib is in the process of SERP review.

Please continue to check back for new reviews and commentary.